Pharma BD Deal Intelligence

Shire plc / Movetis NV

2010 · Acquisition/Merger · $565M · Complete

Announcement Sentiment

Strongly positive

Shire to acquire Movetis at €19/share cash, valuing equity at €428M (~$565M). Adds Belgian GI specialist with Resolor. Closed October 2010 with 99.21% shares tendered.

Did it work? Outcome assessment

Strategic verdict

Failed to Achieve

Financial impact

Impaired/Written Down

Pipeline outcome

Assets Stalled

Assessment window: 5yr post-close.

Key facts

Announced Apr 15, 2010
Closed Oct 12, 2010
Deal value $565M
Deal type Acquisition/Merger
Therapeutic area Chronic constipation
Indications Chronic constipation
Key assets Resolor (prucalopride)
Mechanism Selective 5-HT4 receptor agonist

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals